Patent & IP news for January 20, 2015

Sensory copyright : IPKat, BLACA team up for a joint event from ipkitten.blogspot.com

Talking scents? On Tuesday 24 February the IPKat weblog will be teaming up with the British Literary and Artistic Copyright Association (BLACA) for the second year running to host an exciting meeting on sensory copyright ...

Share via E–mail | Twitter | Facebook

Exodus 2.0: pirate sites and the seven seas from ipkitten.blogspot.com

Last week, the IPKat published a guest post from Spanish IP enthusiast Míchel Olmedo Cuevas on how Spain spent its first month without the benefit of Google News's aggregation service.  Tonight the Kats are ...

Share via E–mail | Twitter | Facebook

Cross-Border Enforcement of Intellectual Property: at last, the book review from ipkitten.blogspot.com

Earlier this month, this Kat posted an announcement concerning the publication of The Research Handbook on Cross-Border Enforcement of Intellectual Property, and explained that, as an interested party (being editor of the publisher's Research ...

Share via E–mail | Twitter | Facebook

The Top Green IP Stories of 2014 from www.greenpatentblog.com

Before we get into the new news, let’s take a quick look back at the top green IP stories of 2014.   5.  GE Wins Ownership of Key Wind Patent In what was something of ...

Share via E–mail | Twitter | Facebook

Ultramercial Requests En Banc Review from www.patentdocs.org

By Michael Borella -- Two months ago, in a long-awaited decision, the Federal Circuit invalided Ultramercial's U.S. Patent No. 7,346,545, directed to online video advertisements, as lacking patent-eligibility under 35 U.S ...

Share via E–mail | Twitter | Facebook

Guest Post on Dan Burk's "Curious Incident of the Supreme Court in Myriad Genetics" from writtendescription.blogspot.com

This is a guest post by Vikram Iyengar, a J.D. student at Stanford Law School. He thanks Prof. Mark Lemley for introducing him to Patent Law, and Prof. Hank Greely for his guidance with ...

Share via E–mail | Twitter | Facebook

Keep Your Eyes Open: Protecting Trademarks Through Active Litigation from www.iplawalert.com

Industry-specific trade shows offer manufacturers the opportunity to market their products and keep tabs on trends in their industry. However, these shows also provide an opportunity for manufacturers to identify counterfeit models of its products ...

Share via E–mail | Twitter | Facebook

What I want to hear in the State of the Union - 2015 from www.athenaalliance.org

According to press accounts (and comments by President Obama himself), tonight's State of the Union address will focus on the economy and the middle class. Much of what the President is expected to propose ...

Share via E–mail | Twitter | Facebook

WIPO Re:Search Programme Celebrates 3 Years And Looks To The Future from www.ip-watch.org

Several years ago, the World Intellectual Property Organization set up a project aimed at helping bring together those with intellectual property rights and those with ideas for research to develop medical products for people in ...

Share via E–mail | Twitter | Facebook

“Difficult Burden” for Inequitable Conduct Justifies Second Deposition of Prosecution Counsel from docketreport.blogspot.com

The court granted defendants' motion to compel a second deposition of plaintiff's original patent counsel and produce documents withheld as work product because of defendants' difficult burden under Therasense. "[Counsel] already has been deposed ...

Share via E–mail | Twitter | Facebook

Teva v. Sandoz: Fact Issues in Claim Construction Reviewed for Clear Error, Ultimate Decision De Novo from writtendescription.blogspot.com

The Supreme Court released its opinion in Teva v. Sandoz this morning, holding 7-2 that fact issues in claim construction are reviewed for clear error, as required by Fed. R. Civ. P. 52(a)(6 ...

Share via E–mail | Twitter | Facebook

Teva v. Sandoz: Deferential Review on Factual Issuse from patentlyo.com

By Jason Rantanen Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc. (2015) Download Opinion Breyer (author), joined by Roberts, Scalia, Kennedy, Ginsburg, Sotomayor, and Kagan; Thomas (dissenting) joined by Alito. One (or both) of us will ...

Share via E–mail | Twitter | Facebook

JUST OUT - Molecular weights at the Supreme Court - Teva v Sandoz from ipkitten.blogspot.com

This moggy covered (here and here) the UK litigation of Generics (t/a Mylan) v Yeda/Teva, in which a patent that covered glatiramer acetate (copolymer 1 or copaxone) was held valid despite having a ...

Share via E–mail | Twitter | Facebook

McKenna on Sampat on Serendipity from writtendescription.blogspot.com

A long running debate in the modeling of innovation is whether discoveries are sure to arise by targeted research investment or by unexpected moments of invention. Suzanne Scotchmer lays out the different models in her ...

Share via E–mail | Twitter | Facebook

Teva v. Sandoz: Partial Deference in Claim Construction from patentlyo.com

by Dennis Crouch As President Clinton taught, the meaning of words is always up for debate.  In the patent realm, actual claim scope often depends upon the particular meaning given to the individual words and ...

Share via E–mail | Twitter | Facebook

Teva Pharmaceuticals USA, Inc. v. Sandoz Inc. -- "Evidentiary Underpinnings" of Claim Construction: Supreme Court Holds Findings of Fact Require Deference from www.patentdocs.org

By Andrew Williams -- In a 7-2 decision authored by Justice Breyer, the Supreme Court held today that an "appellate court must apply a 'clear error,' not de novo, standard of review" to the evidentiary underpinnings ...

Share via E–mail | Twitter | Facebook

Teva wins at Supreme Court by 7-2 vote from ipbiz.blogspot.com

Justices Thomas and Alito dissented.

The  punch line of the dissent is in the last paragraph:  Although it relied on expert testimony to understand  the science underlying petitioners'  claims, the District Court made no findings ...

Share via E–mail | Twitter | Facebook

MVS Filewrapper® Blog: New Supreme Court Decision Alters Review of Claim Construction Decisions from www.filewrapper.com

Post by Dan Lorentzen

 

The Supreme Court has issues a decision in Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc., holding that appellate review of a district court’s decisions relating to subsidiary factual matters made ...

Share via E–mail | Twitter | Facebook

Relevant to Supreme Court decision in Teva v. Sandoz: measures of molecular weight from ipbiz.blogspot.com


Relevant to part III of the Supreme Court decision in Teva v. Sandoz, note the
following text from an earlier post on IPBiz:


A commenter on PatentlyO cites to a PatentDocs post from July 29 ...

Share via E–mail | Twitter | Facebook

Year Ahead: Big IP Developments Loom For US Law In 2015 from www.ip-watch.org

2014 brought major changes to the United States intellectual property system, particularly in the area of patent law. 2015 promises more of the same, as the new Supreme Court ruling in Teva Pharmaceuticals USA v ...

Share via E–mail | Twitter | Facebook